GR3023083T3 - Therapeutical application of histamine H3 receptor agonists, new compounds and their use for the preparation of medicaments - Google Patents

Therapeutical application of histamine H3 receptor agonists, new compounds and their use for the preparation of medicaments

Info

Publication number
GR3023083T3
GR3023083T3 GR970400752T GR970400752T GR3023083T3 GR 3023083 T3 GR3023083 T3 GR 3023083T3 GR 970400752 T GR970400752 T GR 970400752T GR 970400752 T GR970400752 T GR 970400752T GR 3023083 T3 GR3023083 T3 GR 3023083T3
Authority
GR
Greece
Prior art keywords
medicaments
histamine
preparation
receptor agonists
new compounds
Prior art date
Application number
GR970400752T
Other languages
English (en)
Inventor
Jean Charles Schwartz
Monique Garbarg
Jean Michel Arrang
Charon Robin Ganellin
Jeanne Marie Lecomte
Original Assignee
Bioprojet Soc Civ
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprojet Soc Civ, Inst Nat Sante Rech Med filed Critical Bioprojet Soc Civ
Publication of GR3023083T3 publication Critical patent/GR3023083T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR970400752T 1990-04-13 1997-04-08 Therapeutical application of histamine H3 receptor agonists, new compounds and their use for the preparation of medicaments GR3023083T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9004861A FR2660862B1 (fr) 1990-04-13 1990-04-13 Application therapeutique de derives de l'histamine, nouveau derive de l'histamine et utilisation de ces derives pour la preparation de medicaments.

Publications (1)

Publication Number Publication Date
GR3023083T3 true GR3023083T3 (en) 1997-07-30

Family

ID=9395796

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970400752T GR3023083T3 (en) 1990-04-13 1997-04-08 Therapeutical application of histamine H3 receptor agonists, new compounds and their use for the preparation of medicaments

Country Status (8)

Country Link
EP (1) EP0458661B1 (el)
JP (1) JPH0532635A (el)
AT (1) ATE150305T1 (el)
DE (1) DE69125204T2 (el)
DK (1) DK0458661T3 (el)
ES (1) ES2099740T3 (el)
FR (1) FR2660862B1 (el)
GR (1) GR3023083T3 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5321039A (en) * 1990-04-13 1994-06-14 Societe Civile Bioprojet Method of inducing a histamine agonist action on H2 receptors
GB9715816D0 (en) * 1997-07-25 1997-10-01 Black James Foundation Histamine H receptor ligands
US6407132B1 (en) 1997-07-25 2002-06-18 James Black Foundation Limited Substituted imidazole derivatives and their use as histamine H3 receptor ligands
EP1147092A1 (en) 1999-01-18 2001-10-24 Novo Nordisk A/S Substituted imidazoles, their preparation and use
US6908926B1 (en) 1999-04-16 2005-06-21 Novo Nordisk A/S Substituted imidazoles, their preparation and use
US6437147B1 (en) 2000-03-17 2002-08-20 Novo Nordisk Imidazole compounds
US6610721B2 (en) 2000-03-17 2003-08-26 Novo Nordisk A/S Imidazo heterocyclic compounds
EP3378477A1 (en) * 2017-03-21 2018-09-26 BIOPROJET Pharma New therapeutical use of h3-ligands

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758145A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Iso-thio-urees et derives
US3818097A (en) * 1969-10-29 1974-06-18 Smith Kline French Lab Method of inhibiting histamine activity with isothioureas
US3759944A (en) * 1970-10-14 1973-09-18 Smith Kline French Lab Isothioureas and their derivatives
US3954982A (en) * 1972-04-20 1976-05-04 Smith Kline & French Laboratories Limited Pharmaceutical compositions and method of inhibiting H-1 and H-2 histamine receptors
GB8916947D0 (en) * 1989-07-25 1989-09-13 Smith Kline French Lab Medicaments

Also Published As

Publication number Publication date
ES2099740T3 (es) 1997-06-01
FR2660862B1 (fr) 1994-09-23
DK0458661T3 (da) 1997-07-28
DE69125204D1 (de) 1997-04-24
ATE150305T1 (de) 1997-04-15
EP0458661A1 (fr) 1991-11-27
EP0458661B1 (fr) 1997-03-19
FR2660862A1 (fr) 1991-10-18
DE69125204T2 (de) 1997-06-26
JPH0532635A (ja) 1993-02-09

Similar Documents

Publication Publication Date Title
IL78831A (en) 6-(thiazolidin-2,4-dion-5-ylmethyl)chromans and structurally related compounds as hypoglycemic agents
PH27357A (en) Pyrazole derivatives and pharmaceutical compositions comprising the same
HU9600834D0 (en) Quinazoline derivatives
DE3777505D1 (de) 4-aminochinolin-derivate und ihre verwendung als arzneimittel.
NO892799L (no) Fremgangsmaate for fremstilling av benzodiazepinderivater.
FI935360A (fi) Guanidiinialkyyli-1,1-bifosfonihappojohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö
AU4215593A (en) 4-substituted 1,2,4-triazole derivatives
GR3023083T3 (en) Therapeutical application of histamine H3 receptor agonists, new compounds and their use for the preparation of medicaments
AU553041B2 (en) 2-(substituted-benzamidomethyl)-pyrollidines
GR3018687T3 (en) Use of histamine derivatives for the preparation of drugs, new histamine derivatives and drugs.
EP0784973A3 (en) Quinoxaline derivatives for treating tinnitus
DE3862660D1 (de) 2,3-dihydro-2-oxo-3-benzofuranyl-essigsaeurederivate und diese enthaltende arzneimittel.
FI874413A0 (fi) Foerfarande foer framstaellning av aralkyl-4h-1,2,4-triazolderivat.
AU4261196A (en) Use of 2-(4-(azolylbutyl)piperazinyl-(methyl)benzimidazole derivatives for preparing drugs for treating or preventing asthma